Your browser doesn't support javascript.
loading
Deep diversification of an AAV capsid protein by machine learning.
Bryant, Drew H; Bashir, Ali; Sinai, Sam; Jain, Nina K; Ogden, Pierce J; Riley, Patrick F; Church, George M; Colwell, Lucy J; Kelsic, Eric D.
Afiliação
  • Bryant DH; Google Research, Mountain View, CA, USA.
  • Bashir A; Google Research, Mountain View, CA, USA.
  • Sinai S; Wyss Institute for Biologically Inspired Engineering, Boston, MA, USA.
  • Jain NK; Department of Genetics, Harvard Medical School, Boston, MA, USA.
  • Ogden PJ; Dyno Therapeutics, Cambridge, MA, USA.
  • Riley PF; Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA, USA.
  • Church GM; Wyss Institute for Biologically Inspired Engineering, Boston, MA, USA.
  • Colwell LJ; Department of Genetics, Harvard Medical School, Boston, MA, USA.
  • Kelsic ED; Wyss Institute for Biologically Inspired Engineering, Boston, MA, USA.
Nat Biotechnol ; 39(6): 691-696, 2021 06.
Article em En | MEDLINE | ID: mdl-33574611
ABSTRACT
Modern experimental technologies can assay large numbers of biological sequences, but engineered protein libraries rarely exceed the sequence diversity of natural protein families. Machine learning (ML) models trained directly on experimental data without biophysical modeling provide one route to accessing the full potential diversity of engineered proteins. Here we apply deep learning to design highly diverse adeno-associated virus 2 (AAV2) capsid protein variants that remain viable for packaging of a DNA payload. Focusing on a 28-amino acid segment, we generated 201,426 variants of the AAV2 wild-type (WT) sequence yielding 110,689 viable engineered capsids, 57,348 of which surpass the average diversity of natural AAV serotype sequences, with 12-29 mutations across this region. Even when trained on limited data, deep neural network models accurately predict capsid viability across diverse variants. This approach unlocks vast areas of functional but previously unreachable sequence space, with many potential applications for the generation of improved viral vectors and protein therapeutics.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dependovirus / Proteínas do Capsídeo / Aprendizado de Máquina Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dependovirus / Proteínas do Capsídeo / Aprendizado de Máquina Idioma: En Ano de publicação: 2021 Tipo de documento: Article